Fractyl Health (GUTS) Scheduled to Post Earnings on Monday

Fractyl Health (NASDAQ:GUTS) is scheduled to release its earnings data after the market closes on Monday, May 13th. Analysts expect Fractyl Health to post earnings of ($0.30) per share for the quarter.

Fractyl Health (NASDAQ:GUTS) last announced its quarterly earnings results on Monday, April 1st. The company reported ($8.02) EPS for the quarter. The business had revenue of $0.01 million for the quarter. On average, analysts expect Fractyl Health to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Fractyl Health Trading Down 1.9 %

Fractyl Health stock opened at $6.24 on Wednesday. The company’s fifty day simple moving average is $7.30. Fractyl Health has a 52-week low of $5.75 and a 52-week high of $14.50.

Wall Street Analyst Weigh In

GUTS has been the topic of several research analyst reports. Evercore ISI initiated coverage on Fractyl Health in a research report on Wednesday, February 28th. They issued an “outperform” rating on the stock. Bank of America started coverage on shares of Fractyl Health in a research report on Tuesday, February 27th. They set a “buy” rating and a $26.00 target price on the stock. Finally, Morgan Stanley began coverage on shares of Fractyl Health in a research report on Tuesday, February 27th. They issued an “overweight” rating and a $18.00 price target for the company.

Fractyl Health Company Profile

Fractyl Health, Inc, a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.